Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Holding ARWR?
Track your performance easily

Arrowhead Pharmaceuticals (ARWR) Stock Investors

1,420 Followers
Based on 757,311 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ARWR
On average, investors allocate 3.88% of their portfolios to ARWR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,311 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ARWR

0.8%
Last 7
Days
2.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ARWR, out of 757,311 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ARWR Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$24.62
Opened
0.39%
$28.24
Opened
0.00%
$25.00
Opened
1.02%
$25.57
Based on the activity of 14,468 investors who made their portfolios public
The table shows changes in ARWR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ARWR Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.44%
-1.20%
-2.33%
100.84B
Healthcare
Block
4.24%
-1.24%
-2.76%
41.09B
Technology
Enphase Energy
5.11%
-0.86%
-4.26%
16.22B
Technology
Trade Desk
4.83%
-0.98%
-1.41%
52.84B
Technology
DraftKings
5.61%
-1.95%
+0.60%
33.45B
Consumer Cyclical
Applied Materials
4.33%
+0.25%
+5.47%
153.45B
Technology
CVS Health
4.00%
-1.06%
-2.25%
73.49B
Healthcare
Merck & Company
3.78%
-0.87%
+1.02%
300.73B
Healthcare
AbbVie
5.69%
-0.94%
-0.45%
340.80B
Healthcare
RTX
4.24%
-1.28%
-0.76%
157.02B
Industrials
Based on the activity of 757,311 active portfolios
Open your Smart Portfolio

ARWR Investor Analysis

ARWR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.9%
of ARWR holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
ARWR investors between 35–55

Between 35–55

12.2%
Last 30 days
Holdings Change
61.9%
of ARWR holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
ARWR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.2%
of ARWR holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of ARWR stock investors
See who invests in ARWR according to age group and performance.

FAQ

How many retail Investors hold ARWR?
<0.1% of TipRanks' retail investors hold ARWR in their portfolios.
    What is ARWR Investor Sentiment?
    ARWR’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ARWR in the last 7 days?
      ▼ 0.8% of TipRanks' retail investors changed their holding of ARWR in the last 7 days.
        What percentage of retail investors changed their holding of ARWR in the last 30 days?
        ▼ 2.2% of TipRanks' retail investors changed their holding of ARWR in the last 30 days.
          What is the average age of retail investors who hold ARWR?
          The average age of ARWR Holders is between 35–55.
            What other stocks have ARWR investors also bought?
            ARWR Investors also bought BMY, SQ, ENPH, TTD, DKNG, AMAT, CVS, MRK, ABBV, RTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis